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Abstract 
Introduction and Hypothesis: To determine psychosexual outcome after labiaplasty 
in the long-term with specific measures of genital body image and sexual dysfunction. 
Design: A prospective study with a matched comparison group of women not wanting 
labiaplasty. Method: Forty-nine women were compared against a group of 39 women 
matched on age, sexual orientation, ethnicity and marital status. The labiaplasty group 
was assessed before surgery, 3 months after labiaplasty, and in the long term (between 
11 and 42 months) after surgery. The comparison group was assessed at two time-
points (3 months apart) to control for the passage of time. The primary outcome 
measure was the Genital Appearance Satisfaction (GAS) scale. Results: Of the 49 
women receiving labiaplasty, 19 (38.8%) were lost to follow up but were reassessed 
clinically. Twenty-four out of 25 (96%) women in the labiaplasty group showed a 
reliable and clinically significant improvement on the GAS scale 3 months after the 
procedure; and 21/23 (91.3%) showed an improvement at the long-term follow-up. A 
large effect size was found for improvements on the GAS scale in the labiaplasty 
group. Small effect sizes were found for improvements in sexual functioning. Nine 
women obtaining labiaplasty met diagnostic criteria for Body Dysmorphic Disorder 
before the operation; 8 had lost their diagnosis at the 3-month follow-up. 26% 
reported minor side effects. Conclusions: Labiaplasty is effective in improving 
genital appearance and sexual satisfaction but larger studies are required to determine 
the prevalence of potential side effects.  
Keywords: labiaplasty; labioplasty; body dysmorphic disorder; labia; female genital 
cosmetic surgery.   
Brief Summary: Labiaplasty is effective in improving genital appearance at long term 
follow up.  
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Introduction 
Labiaplasty or labia minora reduction is a surgical procedure in women that 
usually reduces the degree of protrusion of the labia minora. The incidence of 
labiaplasty in the National Health Service was 1726 in the year 2010-2011. [1] The 
number of labiaplasties conducted in the private sector is probably greater than in the 
NHS. Braun [2] and Liao, Michala [3] identified up to 18 publications covering 937 
case reports or series of labiaplasty worldwide up to March 2009.  
The motivation for seeking labiaplasty falls into three main categories. [2, 4, 
5]. Women desire the procedure for (i) Aesthetic reasons: for example to reduce self-
consciousness in public situations and feelings of ugliness and abnormality, (ii) 
Functional reasons: for example to reduce discomfort, irritation or pain during (non-
sexual) activities, and (iii) Sexual reasons: for example to reduce dyspareunia or fears 
of negative evaluation by a sexual partner or self-consciousness during intimacy. 
About a third of women seeking labiaplasty have been teased or had negative 
comments made about their genital appearance [6]. 
Some women seeking labiaplasty may have Body Dysmorphic Disorder 
(BDD). This is characterised by a preoccupation with a perceived defect that is not 
observable or appears slight to others while the person’s concern is markedly 
excessive. Crouch, Deans [7] have described the size of the labia of women seeking 
labiaplasty to be within normal published limits. To fulfill the diagnostic criteria for 
BDD, however, the perceived defect must be either significantly distressing or cause 
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impairment in social, occupational or other important areas of functioning. The most 
common preoccupations in BDD are the facial skin, nose, eyes, eyelids, mouth and 
chin - or just being ugly in general. [8, 9] In other areas of the body, a cosmetic 
procedure and the diagnosis of BDD may be associated with a poor outcome [10-12]. 
Surgical complication rates reported for labiaplasty are less than 5% [13] or 
10.8% for side effects [14]. There is only one prospective pilot study of 14 women 
undergoing labiaplasty, [15] and no controlled studies on psychosexual outcomes of 
labiaplasty. All other retrospective case series claim a high level of patient satisfaction 
and anecdotes pertaining to success in the short term. None of these studies have 
utilized standardized outcome measures of sexual function or genital body image 
done independent of the surgeon (although one has used a general body image 
measure).    
The lack of evidence regarding psychosexual outcome of labiaplasty 
especially in the long term has led to significant criticism [7, 16]. The objectives of 
this study were therefore to determine the outcome after labiaplasty with a 
comparison group especially in the long-term. The hypotheses were that women 
receiving labiaplasty would improve on specific measures of genital appearance 
satisfaction and sexual function. 
Materials and methods 
Ethics Permission was granted by the Joint South London and Maudsley Trust 
and Institute of Psychiatry NHS Research Ethics Committee (09/H0807/33). We 
recruited 88 women who were categorised into two groups, those having labiaplasty 
and those not desiring labiaplasty (the comparison group). A STROBE diagram is 
provided for women receiving labiaplasty in Figure 1.  
Participants: 
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(1) Women having labiaplasty   
We recruited 49 women seeking labiaplasty from the following sources: (a) 35 
(71% of the study sample) from a private cosmetic clinic. These were recruited from a 
total of 77 women who had labiaplasty in the recruitment period after being given 
information about the study. (b) 14 (29% of study sample) from an NHS gynaecology 
clinic. These were drawn from a total of 35 women who had a labiaplasty and were 
given information about the study.  
(2) Comparison group   
We recruited 39 women for the comparison group who completed a baseline 
and 3 month follow up questionnaires. They were characterised by not wanting 
labiaplasty. Comparison participants were recruited from MindSearch, a King’s 
College London database containing email addresses of members of the public willing 
to be contacted for research participation.  
Inclusion criteria: all women were required to be aged between 18 and 60 
years of age. Mann-Whitney and Chi Squared tests were used to check whether 
groups were matched; no significant differences were found between the two groups 
in age, sexual orientation, marital status, education, ethnicity, whether or not they had 
children and in symptoms of anxiety or depression (Table 1).   
Procedure: 
Women in both groups were recruited contemporaneously between Jan 2010 
and May 2012. At pre-labiaplasty, participants signed informed consent and 
completed all the questionnaires below, either online (78% of 49 participants) or on 
paper. This process was repeated at 3-month follow-up. The long-term follow-up 
consisted of three of the outcome questionnaires (the GAS, PISQ, and the COPS-L), 
with 91% of 23 participants completing this online. Qualitative data were collected 
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regarding any adverse effects as a result of the procedure between 11 and 42 months 
post-operatively. At both follow-up stages, all participants were contacted first via 
email, then by post with a weblink and paper versions of the questionnaires. If no 
response had been obtained, participants were contacted by telephone.  
The comparison group signed informed consent and completed the full set of 
questionnaires at two time points, 3 months apart, in order to control for the effects of 
time on these measures. At the first time-point, questionnaires were completed online 
by 91% of participants; at follow-up they were completed online by 92% of 
participants (the remainder being completed on paper). All were thanked with a £20 
high street voucher at each stage of the study.  
Labia measurements were taken for women undergoing labiaplasty at the time 
of the procedure. The surgeon measured the degree of protrusion of the labia minora 
and width of each labium with a disposable tape measure. All measurements were 
made in the lithotomy position with minimal stretching of the labia. The width was 
measured anterior-posteriorly from the clitoral hood and the lower aspect of the labia 
minora. We took the average of left and right measurements. Patients at King’s 
College Hospital all had labial trimming using cutting diathermy following which the 
edges are sewn over with Vicryl 3/0 Rapide. Private patients had a range of 
techniques – labial trimming (15), central wedge reduction (9), de-epitheliasation 
technique (3) and superior pedicle flap reconstruction (2).  
Measures 
Participants completed the following self-report questionnaires: 
(1) Genital Appearance Satisfaction (GAS) scale [17, 18]. The GAS scale was our 
primary outcome measure. It contains 11 statements and total scores range from 0 to 
33. Higher scores represent greater dissatisfaction with the genitalia. For calculation 
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of reliable and significant change, we used a mean of 23.2 and standard deviation of 
5.1 for a clinical sample, and mean of 4.75 and SD of 5.6 in a comparison group and a 
Cronbach’s alpha of 0.91 (16).  
(2) Hospital Anxiety and Depression Scale (HADS) [19].  
The HADS is a self-report instrument used to examine the severity of anxiety and 
depressive symptoms in two separate subscales with a range from 0 to 21.  
(3) The Prolapse–Urinary Incontinence Sexual Function Questionnaire (PISQ) 
[20]. The PISQ covers a broad measure of sexual function in women (range 0-125). 
Higher scores represent increasing sexual function.  
(4) Body Image Quality of Life Inventory (BIQLI) [21]. The BIQLI is a self-report 
assessment scale that measures the impact of general body image concerns on a broad 
range of life domains. A more negative score reflects a more negative body image 
affecting the quality of life.   
(5) Cosmetic Procedure Screening for BDD in labiaplasty (COPS-L) [18] This is a 
modification of the original COPS questionnaire [22] which focuses on concerns 
about the appearance of the labia rather than general appearance. The domains follow 
the diagnostic criteria for BDD. Participants who scored more than the cut-off score 
of 45 on the COPS-L were interviewed using a module for DSM-IV disorders [23].  
Statistical Analysis 
Data were analysed using SPSS v21. Data were not normally distributed so 
Mann-Whitney and Chi Squared tests were used to compare the clinical and 
comparison groups at the initial time-point and at the 3-month follow-up. Wilcoxon 
signed-rank tests were used to compare differences within both groups at initial time 
point and at 3-month follow-up, and within the labiaplasty group to compare the 
initial time-point with the long-term follow-up using case deletion. The GAS scale 
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was used to identify the number of women who displayed reliable and clinically 
significant change following labiaplasty. The method summarises changes at the level 
of the individual in the context of observed changes for the whole sample[24, 25]. 
Two questions are addressed: 
1) Has the patient changed sufficiently to be confident that the change is beyond that 
which could be attributed to measurement error? This is termed ‘reliable change’ and 
is measured by the Reliable Change Index (RCI). It is calculated from the standard 
error of the difference (before and after treatment) and takes into account the 
reliability of the instrument (Cronbach’s alpha).    
 2) How does the end state of the patient compare with the scores observed in socially 
and clinically meaningful comparison groups? This is termed ‘clinically significant 
change’. Since the distributions of GAS scores for clinical and comparison 
populations were not over-lapping, we chose to use criterion “b” which examines 
whether the woman moves to within 2 standard deviations of a normative sample 
mean. This is the most stringent but credible criterion when the aim is to determine 
whether a patient returns to a ‘normal’ population. We used an Excel spread sheet, the 
Leeds Reliable Change Indicator to prepare figures (available to download).[26]  
 
Results 
Data were not normally distributed so medians and inter-quartile ranges are reported 
throughout and non-parametric tests were used for analyses.  
Group characteristics prior to intervention 
Table 1 reports the demographics and questionnaire scores for the clinical and 
comparison groups prior to the clinical group receiving labiaplasty procedures. Pre 
labiaplasty, there were no significant differences in the severity of symptoms of 
  10 
anxiety or depression, body image quality of life nor sexual function. As expected, the 
labiaplasty group had significantly higher dissatisfaction towards the appearance of 
their genital area compared with the comparison group as evident on the GAS and the 
COPS-L total scores.  
Sample attrition  
Twenty-six participants in the labiaplasty group completed the 3-month follow 
up and 23 completed the long term follow up (Figure 1). However 4 from the long 
term follow up had not completed the 3 month follow up, so in total 30 of the 49 were 
followed up on at least one occasion. Those lost to follow-up was a result of non-
response to our invitation, although one woman stated they found the questions too 
intrusive. The 19 women in the labiaplasty group who were lost to follow up after 
completing the initial questionnaires were not significantly different to the 26 who 
completed either the 3-month or long term follow up, in terms of age (U =232.50, Z 
=-.868, p = .386), sexual orientation (χ2 =2.711, df =2, p=.258), marital status (χ2 
=4.861, df =3 , p=.182), ), education (χ2 = .091, df =1 , p=.755), ethnicity (χ2 =2.820, 
df = 2, p=.244) and whether or not they had children (χ2 =.377, df = 1, p=.539); nor in 
terms of severity on GAS at baseline  (U = 243.50, Z = -.883, p =.377), HADS 
depression (U = 270.00, Z = -.108 , p =.914), HADS anxiety (U = 251.00, Z = .514, p 
=.607), COPS-L (U = 273.00 , Z = .521, p =.602), PISQ (U = 225.50, Z = .816, p 
=.414) or BIQL (U = 274.50, Z =.011 , p =.991).  
All but one of the 19 women lost to the research follow up were re-assessed 
clinically by the surgeon and reported that they were satisfied with the procedure and 
did not report any adverse side effects. We therefore used case wise deletion for 
missing data in analyses and 3 month and long term follow up.  
Comparisons to a matched-comparison sample  
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Table 2 reports the differences between the two groups on the standardised 
measures at 3-month follow up. There were no significant differences between the 
groups on the GAS, COPS-L, BIQLI, HADS-anxiety or HADS-depression. The 
women in the labiaplasty group scored significantly higher on the PISQ than did 
comparison participants, indicating significantly higher overall sexual function at 3 
months.  
Longitudinal comparisons for labiaplasty group  
Table 3 reports before and after scores on standardised measures for women in 
the labiaplasty group at two time points, pre-labiaplasty versus 3-month follow-up. At 
3-month follow-up, the women scored significantly lower on the GAS and the COPS-
L (with very large effect sizes), implying improved satisfaction and less impairment 
concerning the appearance of their genitalia. They also had lower levels of anxiety, as 
indicated by a significant change on the HADS, and higher overall sexual function as 
indicated by a significant change on the PISQ (moderate effect sizes).  
The scores on the COPS-L and the GAS remained significantly lower at long-
term follow-up with large effect sizes. The GAS had a median score of 7 (IQR of 
2,12) at long term follow up which remained significant improvement compared to 
pre-labiaplasty (Z = -4.202, p < .0005, d = 2.93); the COPS –L had a median score of 
11 (IQR of 4,18) which was also a significant improvement (Z = -4.199, p < .0005, d= 
2.24). The median score on the PISQ was 100 (IQR 89, 104), which was no longer 
significantly different compared to pre-labiaplasty (Z = -1.787, p = .074, d = -0.18). 
Longitudinal comparisons for comparison group 
Significant changes were observed over 3 months for the comparison group on 
several measures. At three months scores on the GAS had decreased with the median 
moving from 7 to 2 (Z = -3.508, p < .0005, d =0.72), scores on the PISQ deteriorated 
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with the median changing from 100 to 97 (Z = -2.049, p = .041, d = 0.22). Effect sizes 
were, however, smaller than for the labiaplasty group over time. There were no 
significant changes on the 4 other measures over time.  
Reliable and clinically significant change on the GAS 
Figure 2 is a visual display of the outcome data at 3 months on 25 labiaplasty 
women who completed a GAS questionnaire at this time-point. (Twenty-six women 
had provided data at 3 months but one questionnaire was incomplete). Each point is a 
patient, the x-axis is the pre-labiaplasty GAS score, and the y-axis is the post- 
labiaplasty GAS score. The diagonal line indicates the cut-off for reliable change, 
with points falling within the tramlines as representing non-reliable change. The 
horizontal and vertical marker lines show criterion b. This examines whether a 
participant moves to within 2 standard deviations of a normative sample mean and 
indicates clinically significant change from assessment to follow up. At 3 months, 
there are 24 patients (96%) who achieve reliable and clinically significant change on 
the GAS score. There is 1 patient (4%) who had reliable improvement but this was not 
clinically significant. Overall the Reliable Change Index is 7.58, Standard Error of the 
Mean is 1.53 and the Standard Error of the Difference is 2.16.  
 
Figure 3 is a visual display of the outcome data at long-term follow-up on the 23 
labiaplasty patients who provided data at this time-point. Participants are assigned the 
same number on Figures 2 and 3. All 23 patients again lie below the diagonal line 
indicating reliable improvement. There are 21 (91%) patients who achieve reliable 
and clinically significant change. There are 2 patients (9%) whose change data is 
reliable but who do not show clinically significant change, one of whom (point 23) 
was in this category at 3 month follow-up. Neither of these patients had BDD. Overall 
  13 
the Reliable Change Index for long-term follow up is 6.57, Standard Error of the 
Mean is 1.53 and the Standard Error of the Difference is 2.16.  
Changes in diagnosis 
We were especially interested in 9 women who were identified as having a 
diagnosis of BDD at interview pre-labiaplasty. All of these women had labia minora 
within normal range according to the surgeon’s measures, thus fulfilling one criterion 
for BDD. The preoccupation was specific to the genitalia (either exclusively or their 
primary feature of concern in 8 women, and was a secondary concern in 1 woman). 
Seven were treated privately and 2 on the NHS. Three months after labiaplasty, only 
one woman retained the diagnosis of BDD.  
Six out of the eight women with BDD made reliable and clinically significant 
improvements on the GAS scale at 3-months (with two missing data). We were only 
able to follow up 4 out of the 8 women with BDD in the long term. These 4 continued 
without a diagnosis of BDD and made reliable and clinically significant changes on 
the GAS. One woman followed up did not lose her diagnosis of BDD. Her 
preoccupation was now focussed on her nose and not on her genitalia. Her concern 
regarding her nose was present pre-labiaplasty but her concerns about her genitalia 
were the primary concern pre-operatively. Of note is that she made reliable and 
significant change on the GAS from 32 to 13 and was pleased with her labiaplasty.  
Ratings of cosmetic and functional success  
Women were asked to rate the functional success on a Likert scale. Eight 
(31%) said the procedure had very much improved functioning, 6 (23%) much 
improved, 5 (19%) moderately improved, 4 (15%) slightly improved and 3 (12%) no 
change.  
Side effects/complications 
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The 23 women followed up in the long-term were asked whether they had 
experienced any long-term adverse effects following the procedure. Seventeen said 
they had no adverse side effects whilst 6 (26%) mentioned one or more side effects 
with (i) urination (for example sometimes spraying) (n=3), (ii) aesthetic concerns - 
noticeable scarring or the labia being jagged (n=2), (iii) slight aching on one side of 
vaginal entrance (1), (iv) reduced sexual arousal (n=2), (v) some discomfort while 
wearing tight clothes (n=1). Only one mentioned regret about having the procedure 
performed.   
Labia measurements   
Comparisons of the average width of the labia minora of the private patients 
(M = 28.09mm, SD = 6.04, n = 23, range 17-41.5) and the NHS patients (M = 
40.27mm, SD = 6.99, n = 11, range 30-52.5) in a non-parametric independent samples 
comparison test demonstrated that the NHS patients appeared to have significantly 
greater labia minora width than the private patients (U = 20.50, Z = -3.91, p < .001). 
However all the women were in the normal range for the general population. For 
example, Lloyd, Crouch [27] found that women had a mean width of 21.8mm (SD = 
9.4, n = 50, range 7-50).    
Discussion  
 We have conducted the first prospective study of women undergoing 
labiaplasty in both the NHS and private sector with a comparison group. We used 
validated questionnaires of genital body image and sexual function, which were 
conducted independent of the surgeons. Ninety-six percent of the women showed 
reliable and clinically significant change on our primary outcome measure (GAS) at a 
3-month follow-up, and 91% fell into this group at long-term follow-up. As a group, 
women who underwent labiaplasty showed very large effect sizes at 3 months in 
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genital body image and had enhanced sexual functioning compared to the comparison  
group. At long-term follow up, they maintained the improvements in genital body 
image but no longer experienced improved sexual functioning. There were minor 
adverse effects reported in about a quarter of our sample but this had not deterred the 
women with only one reporting that she regretted her decision to have the procedure. 
Our study suggested a higher rate of minor side effects (26%) compared to Alter [14] 
although our study collected any reported side-effects.    
The main weakness of the study is that we were only able to recruit 43% of 
consecutive patients who underwent labiaplasty and we do not therefore know 
whether our sample is representative. This recruitment or attrition rate is comparative 
to that of the only other prospective study of labiaplasty[15], and may reflect 
characteristics of the clinical population (for example, reluctance to discuss anxieties 
about their genitalia, or general avoidant tendencies). Another possible weaknesses is 
that we did not take labia measurements for our comparison group; however given 
that our clinical group has measurements within the normal range (see Results), this 
would not seem critical.  
The main strengths of the study are that we used validated questionnaires and 
that the assessments were undertaken independent of the surgeons and conducted in 
the long term in the labiaplasty group. However this may also contribute to a 
weakness in that it was more difficult to capture the data when patients attended for 
their 3-month follow up appointment. Another weakness is that we were unable to 
follow up 19/49 (38.8%) of the women we recruited. However the women lost to 
follow up were no different in the baseline measures to the women who were 
followed up. Furthermore all but one of the women was followed up clinically and 
reported satisfaction to the surgeon. The study has relatively small numbers and 
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therefore we cannot comment on the prevalence of adverse events. Previous case 
series suggest minor side effects occur in about 10% and a very large case series 
would be required to provide an accurate estimate of prevalence of side effects. 
However it is challenging to recruit consecutive cases especially in the private sector 
to participate in such research and there is no incentive to participate after the surgery 
is completed.  
Women with BDD did surprisingly well at 3 month follow up in that 8 out of 9 lost 
their diagnosis. This is a small sample and thus must be interpreted cautiously but it 
suggests that a diagnosis of BDD is not a contra-indication to labiaplasty in the short 
term. It was not possible to interpret data in the long term since we were only able to 
follow up 50% of the women with BDD. It suggests that the risk in BDD is relatively 
low in the short term for a procedure in which there is an obvious desired change (e.g. 
reduction of labia minora or breast augmentation) compared to a procedure where the 
change may be ambiguous (e.g. rhinoplasty) and if the symptoms of the BDD are in 
the mild range without excessive distress and shame.  However in BDD, if another 
body feature is also of significant concern then the preoccupation may still transfer to 
a different feature or a new preoccupation may emerge in the long term. Further 
prospective studies are required to clarify this.  
Crouch, Deans [7] and Michala, Liao [16] recommend providing reassurance about 
the diversity of normal vulval appearance and counseling to explore issues leading to 
a request for surgery. We agree that it would be desirable to evaluate a psychological 
intervention especially in those women seeking labiaplasty who have been teased or 
received comments about the appearance of their genitals. [6] However at present no 
data are available on the psychosexual outcome or genital satisfaction of either 
reassurance by a surgeon or subsequent counseling. Whilst there is evidence of 
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benefit from cognitive behaviour therapy (CBT) for body image problems or body 
dysmorphic disorder, [28, 29] CBT is not a generic intervention and has not yet been 
developed for this population. A strategy of reassurance may be similar to informing a 
woman seeking breast augmentation that her breast size is within normal limits and 
does not therefore require surgery. Equally counseling may be difficult in those with 
medically unexplained symptoms. The first step would therefore be to evaluate the 
role of reassurance or a psychological intervention on a standardised scale in a 
consecutive case series in order to estimate an effect size for a future randomised 
controlled trial of labiaplasty -v- a psychological intervention.   
Conclusion 
We provide an initial benchmark for the psychosexual improvements that 
occur after labiaplasty. We recommend that specific measures of genital body image, 
sexual function and side-effects be used in outcome studies of labiaplasty or of any 
psychological interventions for women dissatisfied with their genitalia. As a 
minimum we would recommend the use of the GAS, COPS-L and either the PISQ or 
the Female Sexual Functioning Index (FSFI) [30] for future audit and outcome studies 
including psychological interventions.  
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Table 1. Participant demographics and baseline for labiaplasty and comparison group  
 Labiaplasty  
(n= 49) 
MDN (IQR) 
Control 
(n =39) 
MDN (IQR) 
Comparison  
& effect size 
Age 
 
34 (25-43) 28 (25-34) U =  728.00, Z = -1.637,   
p = .102 
Sexual orientation:   
Only opposite sex 
Mainly opposite sex 
Equally both sexes 
Mainly same sex 
Only same sex 
 
 
39 (80%) 
8 (16%) 
1 (2%) 
0 
0 
 
 
28 (72%) 
6 (15%) 
5 (13%) 
0 
0 
 
 
 
 
χ 2 (2) = 3.869,  
p = .145  
 
Marital status: n (%) 
Single 
Separated/Divorced 
Married/Cohabiting 
Widowed 
 
25 (51%) 
8 (16%) 
15 (31%) 
1 (2%) 
 
22 (56%) 
3 (8%) 
14 (36%) 
0 (%) 
 
 
χ2 (3) = 2.393,  
p = .495 
 
 
Children: n (%) 
 
17 (35%) 
 
8 (21%) 
 
χ2 (1) = 2.147,  
p = .143 
Ethnicity: n (%) 
White 
Black/Black British 
Mixed 
Other 
Missing 
 
44 (90%) 
0 
1 (2%) 
2 (4%) 
2 (4%) 
 
32 (84%) 
2 (5%) 
3 (8%) 
1 (3%) 
1 (3%) 
 
 
χ2 (3) = 4.324,  
p = .229 
 
 
 
HADS Anxiety 
 
9 (5,12) 
 
6 (4,12) 
 
U =  838.00, Z = -.683,  
p = .495, d = -0.12 
 
HADS Depression 
 
2 (1,6) 
 
3 (1,6) 
 
U =  887.00, Z = -.258,  
p = .796, d = 0.13 
 
BIQLI 
  
 
0.4  
(-0.9, 1.1) 
 
0.7  
(-0.6, .8) 
 
U =  759.50, Z = -1.362,  
p = .173, d = 0.28 
 
GAS 
 
 
23.5  
(20, 27) 
 
7  
(6, 8) 
 
U =  12.50, Z = -7.897,  
p < .0005, d = -3.68 
 
COPS-L  
 
43.9  
(30.3, 53.5) 
3  
(2, 6) 
U =  17.00, Z = -7.891,  
p < .0005, d = -3.17 
 
PISQ  
 
98.5  
(85.8, 104.1) 
100.1  
(89, 107.1) 
U =  752.50, Z = -1.092,  
p = .275, d = 0.23 
 
MDN = median, IQR = interquartile range, HADS = Hospital Anxiety and Depression Scale, BIQLI = 
Body Image Quality of Life Index, GAS = Genital Appearance Satisfaction, COPS-L = Cosmetic 
Procedures Scale – Labia, PISQ = Pelvic Organ Prolapse– Urinary Incontinence Sexual Function 
Questionnaire 
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Table 2. Comparisons of the labiaplasty and control groups: scores on standardised questionnaires at 3-
month follow up  
 
 
 
MDN = median, IQR = interquartile range, HADS = Hospital Anxiety and Depression Scale, BIQLI = 
Body Image Quality of Life Index, GAS = Genital Appearance Satisfaction, COPS-L = Cosmetic 
Procedures Scale – Labia, PISQ = Pelvic Organ Prolapse– Urinary Incontinence Sexual Function 
Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Labiaplasty 
(N=26)  
MDN (IQR) 
Control 
(N = 39) 
MDN (IQR) 
Comparison Effect size 
HADS anxiety 
 
6 (3.5, 7) 5 (3, 11) U =  448.00, Z = -0.029, p = .976 
 
d = 0.26 
HADS 
depression 
2 (0.5, 7) 2.5 (1, 5.8) U =  437.00, Z = -0.193, p = .847 
 
d = 0.15 
BIQLI 
  
0.5 (-0.3, 1.9) 0.0 (-0.6, 1.7) U =  375.00, Z = -0.937, p = .349 
 
d = -0.29 
GAS 
 
4 (1, 11.5) 2 (0, 6) U =  323.50, Z = -1.728, p= .084 
 
d = -0.46 
COPS-L  
 
4.8 (1, 14.3) 3 (1.3, 6.3) U =  405.5, Z = -0.896, p = 0.37 
 
d = -0.43 
PISQ  
 
103.7 (95.9, 108.3) 97 (88.9, 103.2) U =  222.50, Z = -2.415, p = .016 
 
d = -0.46 
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Table 3. Comparisons of the labiaplasty group from pre-labiaplasty to 3-month  
follow-up on standardised questionnaires (data deleted case-wise, N = 26) 
 
 Pre-labiaplasty 
MDN (IQR) 
3-month 
follow-up 
MDN (IQR) 
Comparison Effect size 
HADS 
anxiety 
 
9 (5, 11.5) 6 (3.5, 7) Z = - 2.79, p = .005 
 
d =0.68 
HADS 
depression 
 
2 (1, 6) 2 (0.5, 7) Z = - .13, p = .895 
 
d = -0.01 
BIQLI 
  
-.06 (-1.1, 1.6) 0.5 (-0.3, 1.9) Z = - 1.84, p = .066 
 
d = -0.41 
GAS 
 
24.5 (20, 29) 4 (1, 11.5) Z = -4.38, p < .0005 
 
d = 3.35 
COPS-L  
 
44 (31.9, 53.5) 4.8 (1, 14.3) Z = -4.46, p < .0005 
 
d = 3.04 
PISQ  
 
98 (84.0, 103) 103.7 (95.9, 108.3) Z = - 3.30, p = .001 
 
d = -0.66 
MDN = median, IQR = interquartile range. HADS = Hospital Anxiety and Depression Scale, BIQLI = 
Body Image Quality of Life Index, GAS = Genital Appearance Satisfaction, COPS-L = Cosmetic 
Procedures Scale – Labia, PISQ = Pelvic Organ Prolapse– Urinary Incontinence Sexual Function 
Questionnaire 
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Figure 1: Flow chart for women receiving labiaplasty 
 
 
 
 
 
 
  All women recruited and completed   
pre-operative questionnaire 
     49 Total ⏐ 14 NHS⏐ 35 Private 
 All women who received labiaplasty 
112 Total ⏐35 NHS⏐ 77 Private 
 
 Women followed up at 3-months  
26 Total ⏐10 NHS⏐ 16 Private 
 
 Women followed up at 11-42 months  
23 Total ⏐ 9 NHS⏐ 14 Private 
 
Declined participation    
63 Total 
Lost to 3 month follow up 
N= 23 (of whom 22 were 
followed up clinically) 
 
Lost to 11- 42 follow up  
N= 7   
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Figure 2: Reliable and clinically significant change on the GAS for labiaplasty 
group at 3-month follow-up (n = 25) 
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Figure 3: Reliable and clinically significant change on the GAS for labiaplasty 
group at long-term follow-up (n = 23) 
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